Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | phosphodiesterase 5A, cGMP-specific | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.0491 | 0.0128 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Brugia malayi | RNA binding protein | 0.0065 | 0.2586 | 0.2418 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.0491 | 0.0441 |
Plasmodium vivax | pyruvate kinase, putative | 0.0034 | 0.0491 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0174 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.2586 | 0.2303 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0037 | 0.0686 | 0.0731 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0491 | 0.0134 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0034 | 0.0491 | 0.0134 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0037 | 0.0686 | 0.114 |
Toxoplasma gondii | hypothetical protein | 0.0065 | 0.2546 | 1 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0074 | 0.3161 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0168 | 0.9544 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0037 | 0.0686 | 0.0347 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Chlamydia trachomatis | pyruvate kinase | 0.0034 | 0.0491 | 0.5 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Echinococcus granulosus | dual 3'5' cyclic AMP and GMP phosphodiesterase | 0.0074 | 0.3161 | 0.2899 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.2586 | 0.2418 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Plasmodium falciparum | pyruvate kinase | 0.0034 | 0.0491 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.2586 | 0.2418 |
Schistosoma mansoni | alpha glucosidase | 0.0037 | 0.0686 | 0.0331 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0037 | 0.0686 | 0.114 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | cone cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.2586 | 0.2303 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0034 | 0.0491 | 0.0134 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0034 | 0.0491 | 0.5 |
Trichomonas vaginalis | rod cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.0033 | 0.0368 | 0.0368 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0037 | 0.0686 | 0.114 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0144 | 0.7959 | 0.7881 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0034 | 0.0491 | 0.5 |
Giardia lamblia | Pyruvate kinase | 0.0034 | 0.0491 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.2586 | 0.2303 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0037 | 0.0686 | 0.114 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0037 | 0.0686 | 0.114 |
Echinococcus multilocularis | geminin | 0.0174 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.2586 | 0.2418 |
Echinococcus multilocularis | pyruvate kinase | 0.0034 | 0.0491 | 0.0491 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0491 | 0.0134 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0168 | 0.9544 | 0.9544 |
Schistosoma mansoni | hypothetical protein | 0.0174 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0074 | 0.3161 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0491 | 0.0134 |
Trichomonas vaginalis | cAMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0065 | 0.2546 | 0.7799 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0037 | 0.0686 | 0.114 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.2586 | 0.2303 |
Trichomonas vaginalis | high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0037 | 0.0686 | 0.0331 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.2586 | 0.2586 |
Schistosoma mansoni | pyruvate kinase | 0.0034 | 0.0491 | 0.0128 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0065 | 0.2546 | 0.7799 |
Schistosoma mansoni | camp/cgmp cyclic nucleotide phosphodiesterase | 0.0074 | 0.3161 | 0.2899 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.2586 | 0.2418 |
Echinococcus granulosus | pyruvate kinase | 0.0034 | 0.0491 | 0.0128 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0168 | 0.9544 | 0.9544 |
Trichomonas vaginalis | cAMP/cGMP cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0037 | 0.0686 | 0.5 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0034 | 0.0491 | 0.0441 |
Trichomonas vaginalis | cGMP-inhibited 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0037 | 0.0686 | 0.5 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.005 | 0.1568 | 0.4296 |
Echinococcus multilocularis | pyruvate kinase | 0.0034 | 0.0491 | 0.0491 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0065 | 0.2546 | 0.7799 |
Schistosoma mansoni | alpha-glucosidase | 0.0144 | 0.7959 | 0.7881 |
Trichomonas vaginalis | calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0037 | 0.0686 | 0.0686 |
Trichomonas vaginalis | cAMP and cAMP-inhibited cGMP 3,5-cyclic phosphodiesterase, putative | 0.005 | 0.1568 | 0.4296 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Mycobacterium ulcerans | pyruvate kinase | 0.0034 | 0.0491 | 0.5 |
Onchocerca volvulus | 0.0097 | 0.4744 | 1 | |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0037 | 0.0686 | 0.114 |
Echinococcus granulosus | pyruvate kinase | 0.0034 | 0.0491 | 0.0128 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.2586 | 0.2303 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.2586 | 0.2303 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.005 | 0.1568 | 0.4033 |
Trichomonas vaginalis | cAMP-specific phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0037 | 0.0686 | 0.095 |
Loa Loa (eye worm) | pyruvate kinase | 0.0034 | 0.0491 | 0.0134 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0037 | 0.0686 | 0.0347 |
Echinococcus multilocularis | dual 3',5' cyclic AMP and GMP phosphodiesterase | 0.0074 | 0.3161 | 0.3161 |
Trichomonas vaginalis | cyclic nucleotide phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0037 | 0.0686 | 0.114 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0.0686 | 0.0731 |
Trichomonas vaginalis | cGMP-dependent 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0037 | 0.0686 | 0.114 |
Trypanosoma brucei | glucosidase, putative | 0.0037 | 0.0686 | 0.0731 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.2586 | 0.2418 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0.0686 | 0.0731 |
Trichomonas vaginalis | cGMP-specific 3,5-cyclic phosphodiesterase, putative | 0.0074 | 0.3161 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0168 | 0.9544 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0168 | 0.9544 | 0.9527 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.